Category Archives: Geen categorie

More information and registration here.

Alliance for the Prudent Use of Antibiotics (APUA) is organising a seminar on 25th of May at 12.00-13.30 GMT. The program and registration procedure are accessible here.

Hereby an overview of the ABACUS related work that will be presented at ECCMID 2022: Mini- Flash session: ‘ Exploring the case for a standardised physical appearance of oral generic antibiotics: a summary of expert roundtable meetings’. Poster presentation: ‘Learning from the Red Line program in India on the labelling of antibiotics: a qualitative interviewContinue reading “ABACUS at ECCMID 2022”

We conducted an economic impact analysis to study the repercussion of inappropriate antibiotic use. We specifically looked at upper respiratory tract infections (URIs) in Ghana. Our study indicates that inappropriate antibiotic use leads to substantial economic costs in a LMIC setting that could have been prevented. We recommend investment in novel strategies to counter theseContinue reading “New ABACUS publication”

Causing 1.27 million deaths per year, antibiotic resistance is one of the greatest and most urgent cross-border public health threats of our time. However, the global community was late to the table to pick up on the systems failure of antibiotic resistance. Initiatives and collaborations have been initiated since 2015, but stronger globally coordinated governanceContinue reading “Systemwide response to antibiotic resistance requires effective and sustainable global governance – ReAct Blog”

Summary: Despite the evidence that highlights the need for implementation research to achieve the United Nation’s Sustainable Development Goals, global health researchers often do not incorporate core implementation components in their work systematically. This guide aims to address the lack of guidance describing how to apply a range of theoretical approaches and methods that addressContinue reading “Interesting read in BMJ GH: A guide to systems-level, participatory, theory-informed implementation research in global health”

The COVID-19 pandemic has underlined the importance of an efficient and equitable supply of and access to essential health products. These factors are equally pertinent to the antimicrobial resistance pandemic, in which access to a portfolio of existing and pipeline antimicrobials plus complementary diagnostics is crucial. This Viewpoint focuseson market shaping in low-income and middle-incomeContinue reading “Lancet GH viewpoint on global access to antimicorbials and diagnostics”

JPIAMR workshop on Wednesday 9th of December 2021 12.00-16.00 CET.

An overview of WHO events and campaign materials are accessible here.